Cognition Therapeutics, Inc. (CGTX)
NGM · Common · CUSIP 19243B102
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CGTX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
19243B102
Market Cap
Micro Cap
IPO
10/8/2021 · $12.00/share
Business: Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company leveraging its expertise in the σ-2 (sigma-2) receptor to develop innovative, small molecule therapeutics targeting age-related degenerative diseases.

Company Contact

CEO
Lisa Ricciardi
CFO
John Doyle
Headquarters
2500 Westchester Ave, Purchase, NY 10577
Phone
412-481-2210
Investor Relations
412-481-2210 · info@cogrx.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »